BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 15948934)

  • 1. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.
    Björkman S
    Br J Clin Pharmacol; 2005 Jun; 59(6):691-704. PubMed ID: 15948934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model.
    Björkman S; Wada DR; Berling BM; Benoni G
    J Pharm Sci; 2001 Sep; 90(9):1226-41. PubMed ID: 11745776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?
    Björkman S
    Clin Pharmacokinet; 2006; 45(1):1-11. PubMed ID: 16430308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.
    Ginsberg G; Hattis D; Russ A; Sonawane B
    J Toxicol Environ Health A; 2004 Feb; 67(4):297-329. PubMed ID: 14713563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults.
    Li GF; Zheng QS; Yu Y; Zhong W; Zhou HH; Qiu F; Wang G; Yu G; Derendorf H
    Clin Pharmacokinet; 2019 Jul; 58(7):927-941. PubMed ID: 30767128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.
    Sidhu P; Peng HT; Cheung B; Edginton A
    Can J Physiol Pharmacol; 2011 May; 89(5):365-82. PubMed ID: 21627485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach.
    Rasool MF; Khalid R; Imran I; Majeed A; Saeed H; Alasmari F; Alanazi MM; Alqahtani F
    Drug Metab Dispos; 2020 Jul; 48(7):570-579. PubMed ID: 32393652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
    Zhang Z; Unadkat JD
    Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A re-evaluation and validation of ontogeny functions for cytochrome P450 1A2 and 3A4 based on in vivo data.
    Salem F; Johnson TN; Abduljalil K; Tucker GT; Rostami-Hodjegan A
    Clin Pharmacokinet; 2014 Jul; 53(7):625-36. PubMed ID: 24671884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Developmental Midazolam and 1-Hydroxymidazolam Data with Pediatric Physiologically Based Modeling to Assess Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyl Transferase 2B4 Ontogeny In Vivo.
    Johnson TN; Howgate EM; de Wildt SN; Turner MA; Rowland Yeo K
    Drug Metab Dispos; 2023 Aug; 51(8):1035-1045. PubMed ID: 37169511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.
    Rasool MF; Khalil F; Läer S
    Clin Pharmacokinet; 2015 Sep; 54(9):943-62. PubMed ID: 25773479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Pediatric Rectal Absorption, Drug Disposition, and Sedation Level for Midazolam Gel Using Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling.
    Zhu J; Zhou S; Wang L; Zhao Y; Wang J; Zhao T; Li T; Shao F
    Mol Pharm; 2024 May; 21(5):2187-2197. PubMed ID: 38551309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK model.
    Abduljalil K; Jamei M; Rostami-Hodjegan A; Johnson TN
    AAPS J; 2014 May; 16(3):568-76. PubMed ID: 24700271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considering Age Variation When Coining Drugs as High versus Low Hepatic Extraction Ratio.
    Salem F; Abduljalil K; Kamiyama Y; Rostami-Hodjegan A
    Drug Metab Dispos; 2016 Jul; 44(7):1099-102. PubMed ID: 26864786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
    Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I
    Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.
    Abduljalil K; Pan X; Pansari A; Jamei M; Johnson TN
    Clin Pharmacokinet; 2020 Apr; 59(4):501-518. PubMed ID: 31587145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure.
    Brussee JM; Vet NJ; Krekels EHJ; Valkenburg AJ; Jacqz-Aigrain E; van Gerven JMA; Swart EL; van den Anker JN; Tibboel D; de Hoog M; de Wildt SN; Knibbe CAJ
    Br J Clin Pharmacol; 2018 Feb; 84(2):358-368. PubMed ID: 29072785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children.
    Zhou W; Johnson TN; Bui KH; Cheung SYA; Li J; Xu H; Al-Huniti N; Zhou D
    Clin Pharmacol Ther; 2018 Jul; 104(1):188-200. PubMed ID: 29027194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.